Floatz logo

NEPENTHE

Chronic Wounds

Institut CurieSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Chronic Wounds cohort.

Asset / SponsorPhaseRating
DESFERRIOXAMINE B
TauTona Group
Phase 1/2CCC
HYALURONATE
Nakhia Impex LLC
N/AD
ha35
Nakhia Impex LLC
N/AD
Arginine Butyrate
Susan P. Perrine
Phase 2NR

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →